Lidanserin
Product Specifications
UNSPSC Description
Lidanserin (ZK-33839) acts as a 5-HT2A and α1-adrenergic receptor antagonist.
Target Antigen
5-HT Receptor; Adrenergic Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein;Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease; Endocrinology
Assay Protocol
https://www.medchemexpress.com/Lidanserin.html
Purity
98.0
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C1NCC(C2=CC=C(OC)C(OCCCN3CCC(C(C4=CC=C(F)C=C4)=O)CC3)=C2)C1
Molecular Weight
454.53
References & Citations
[1]Boichenko I, et al. Chemical Ligand Space of Cereblon. ACS Omega. 2018 Sep 14;3(9):11163-11171.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-101815/Lidanserin-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-101815/Lidanserin-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
73725-85-6
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Saccharomyces cerevisiae Putative meiotic phospholipase SPO1 (SPO1) , partial
Recombinant Archaeoglobus fulgidus Probable deoxyhypusine synthase 2 (dys2)
Recombinant Archaeoglobus fulgidus Probable deoxyhypusine synthase 2 (dys2)
Recombinant Archaeoglobus fulgidus Probable deoxyhypusine synthase 2 (dys2)